Source: Journal of biopharmaceutical statistics [J Biopharm Stat] 2018; Vol. 28 (2), pp. 320-332. Date of Electronic Publication: 2017 Nov 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر

Academic Journal

Characteristics of pivotal trials and FDA review of innovative devices.

Authors : Rising JP; The Pew Charitable Trusts, Washington, District of Columbia, United States of America.; Moscovitch B

Subjects: Clinical Trials, Phase III as Topic* ; Device Approval* ; United States Food and Drug Administration*

Source: PloS one [PLoS One] 2015 Feb 04; Vol. 10 (2), pp. e0117235. Date of Electronic Publication: 2015 Feb 04 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

اقرأ أكثر

Academic Journal

Joint modeling of multiple longitudinal patient-reported outcomes and survival.

Authors : Hatfield LA; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.; Boye ME

Subjects: Longitudinal Studies* ; Models, Statistical* ; Research Design*

Source: Journal of biopharmaceutical statistics [J Biopharm Stat] 2011 Sep; Vol. 21 (5), pp. 971-91.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print Cited Medium: Internet ISSN: 1520-5711

تفاصيل العنوان

اقرأ أكثر

Periodical

Clinical research. Testing a novel strategy against Parkinson's disease.

Authors : Couzin J

Subjects: Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/economics ; Dietary Supplements*; Creatine/Creatine/Creatine/*therapeutic use

Source: Science (New York, N.Y.) [Science] 2007 Mar 30; Vol. 315 (5820), pp. 1778.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ أكثر

Academic Journal

The role of the data safety monitoring board: why was the Avastin phase III clinical trial stopped?

Authors : McLemore MR; Department of Physiologic Nursing, School of Nursing, University of California, San Francisco, USA.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Clinical Trials Data Monitoring Committees*

Source: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2006 Apr; Vol. 10 (2), pp. 153-4.Publisher: Oncology Nursing Press Country of Publication: United States NLM ID: 9705336 Publication Model: Print Cited

تفاصيل العنوان

اقرأ أكثر

Editorial & Opinion

Support for the RV144 HIV vaccine trial.

Authors : AIDS Vaccine Advocacy Coalition

Subjects: AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; Clinical Trials, Phase III as Topic*; HIV Infections/HIV Infections/HIV Infections/*prevention & control

Source: Science (New York, N.Y.) [Science] 2004 Jul 09; Vol. 305 (5681), pp. 177-80; author reply 177-80.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ أكثر

Editorial & Opinion

Outstanding questions on HIV vaccine trial.

Authors : Jefferys R; Harrington M

Subjects: AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/administration & dosage ; AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; Clinical Trials, Phase III as Topic*

Source: Science (New York, N.Y.) [Science] 2004 Jul 09; Vol. 305 (5681), pp. 180; author reply 180.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ أكثر

Editorial & Opinion

Support for the RV144 HIV vaccine trial.

Authors : Belshe R; Franchini G; Girard MP

Subjects: AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/administration & dosage ; AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; Clinical Trials, Phase III as Topic*

Source: Science (New York, N.Y.) [Science] 2004 Jul 09; Vol. 305 (5681), pp. 177-80; author reply 177-80.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

تفاصيل العنوان

اقرأ أكثر

Academic Journal

A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials.

Authors : Becker C

Subjects: Clinical Trials, Phase III as Topic* ; Emergency Treatment*; Blood Substitutes/Blood Substitutes/Blood Substitutes/*therapeutic use

Source: Modern healthcare [Mod Healthc] 2004 Apr 12; Vol. 34 (15), pp. 30-1, 34.Publisher: Crain Communications Country of Publication: United States NLM ID: 7801798 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ أكثر

Periodical

US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.

Authors : Agnew B

Subjects: Clinical Trials, Phase III as Topic* ; International Cooperation*; AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*administration & dosage

Source: Bulletin of the World Health Organization [Bull World Health Organ] 2004 Mar; Vol. 82 (3), pp. 231. Date of Electronic Publication: 2004 Apr 16.Publisher: World Health Organization Country of Publication: Switzerland NLM ID: 7507052 Publication Model: Print-Electronic Cited Medium: Print

تفاصيل العنوان

اقرأ أكثر

نتائج البحث

فلترة النتائج

Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarity.

Characteristics of pivotal trials and FDA review of innovative devices.

Joint modeling of multiple longitudinal patient-reported outcomes and survival.

Clinical research. Testing a novel strategy against Parkinson's disease.

The role of the data safety monitoring board: why was the Avastin phase III clinical trial stopped?

Support for the RV144 HIV vaccine trial.

Outstanding questions on HIV vaccine trial.

Support for the RV144 HIV vaccine trial.

A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials.

US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.

اتصل بنا

اتبع